Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1952 Jun;28(6):385–407.

Recent Advances in Treatment of Inoperable Cancer*

The L. Duncan Bulkley Lecture

Lloyd F Craver
PMCID: PMC1877194  PMID: 14925642

Full text

PDF
385

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BATEMAN J. C., KLOPP C. T., CROMER J. K. Hematologic effects of regional nitrogen mustard therapy. Blood. 1951 Jan;6(1):26–38. [PubMed] [Google Scholar]
  2. BIERMAN H. R., MILLER E. R., BYRON R. L., DOD K. S., KELLY K. H., BLACK D. H. Intra-arterial catheterization of viscera in man. Am J Roentgenol Radium Ther. 1951 Oct;66(4):555–568. [PubMed] [Google Scholar]
  3. BRENDLER H., CHASE W. E., SCOTT W. W. Prostatic cancer; further investigation of hormonal relationships. Arch Surg. 1950 Sep;61(3):433–440. [PubMed] [Google Scholar]
  4. BURCHENAL J. H., KARNOFSKY D. A., KINGSLEY-PILLERS E. M., SOUTHAM C. M., MYERS W. P. L., ESCHER G. C., CRAVER L. F., DARGEON H. W., RHOADS C. P. The effects of the folic acid antagonists and 2,6-diaminopurine on neoplastic disease, with special reference to acute leukemia. Cancer. 1951 May;4(3):549–569. doi: 10.1002/1097-0142(195105)4:3<549::aid-cncr2820040308>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  5. GODWIN J. T., ESCHER G. C. Hormone-treated primary operable breast carcinoma; a pathological study of 33 cases. Cancer. 1951 Jan;4(1):136–140. doi: 10.1002/1097-0142(195101)4:1<136::aid-cncr2820040114>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  6. KARNOFSKY D. A., BURCHENAL J. H., ARMISTEAD G. C., Jr, SOUTHAM C. M., BERNSTEIN J. L., CRAVER L. F., RHOADS C. P. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use. AMA Arch Intern Med. 1951 Apr;87(4):477–516. doi: 10.1001/archinte.1951.03810040002001. [DOI] [PubMed] [Google Scholar]
  7. LIMARZI L. R. Diagnostic and therapeutic aspects of multiple myeloma. Med Clin North Am. 1951 Jan;35(1):189–226. [PubMed] [Google Scholar]
  8. NESBIT R. M., BAUM W. C. Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases. J Am Med Assoc. 1950 Aug 12;143(15):1317–1320. doi: 10.1001/jama.1950.02910500019005. [DOI] [PubMed] [Google Scholar]
  9. RUNDLES R. W., REEVES R. J. Multiple myeloma. II. Variability of roentgen appearance and effect of urethane therapy on skeletal disease. Am J Roentgenol Radium Ther. 1950 Nov;64(5):799–809. [PubMed] [Google Scholar]
  10. SOUTHAM C. M., CRAVER L. F., DARGEON H. W., BURCHENAL J. H. A study of the natural history of acute leukemia with special reference to the duration of the disease and the occurrence of remissions. Cancer. 1951 Jan;4(1):39–59. doi: 10.1002/1097-0142(195101)4:1<39::aid-cncr2820040105>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  11. TRUMP J. G., WRIGHT K. A., EVANS W. W., HARE H. F., LIPPINCOTT S. W., Jr Two million volt roentgen therapy using rotation. Am J Roentgenol Radium Ther. 1951 Oct;66(4):613–623. [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES